BioForm to Announce First Quarter Fiscal 2008 Financial Results and Host Conference Call and Webcast on December 13, 2007
December 05 2007 - 8:30AM
PR Newswire (US)
SAN MATEO, Calif., Dec. 5 /PRNewswire-FirstCall/ -- BioForm
Medical, Inc. (NASDAQ:BFRM) announced that on Thursday, December
13, 2007, it will report its September 30, 2007 first quarter
fiscal year 2008 financial results. The Company will issue the
earnings press release after the NASDAQ Global Market closes and
will hold a conference call with investors at 2:30 p.m. Pacific
Time (5:30 p.m. Eastern Time). BioForm Chief Executive Officer
Steve Basta and Chief Financial Officer Derek Bertocci will discuss
the Company's results for the first quarter fiscal year 2008 and
its future outlook for the fiscal year 2008. The conference call
will be webcast live on the Investor Relations section of BioForm's
website at http://www.bioform.com/. The online archive of the
broadcast will be available approximately 90 minutes after the live
call and will continue to be available for two weeks. The
conference call may be accessed by dialing 888.661.5138 for callers
in the U.S. and 913.312.0952 for international callers. Please
notify the operator that you would like to join "BioForm Medical's
First Quarter Earnings Call" and provide the participant code
"2949717", if prompted. About BioForm Medical, Inc.: BioForm
Medical, Inc. is a medical aesthetics company headquartered in San
Mateo, California. BioForm is dedicated to bringing doctors and
their patients safe and effective products for use in the
dermatology, plastic surgery and ENT markets. BioForm's products
include Radiesse(R), a long-lasting filler for use in facial
aesthetics and vocal fold insufficiency, and Coaptite(R) for
treating female stress urinary incontinence which is marketed
through a partnership with Boston Scientific Corporation. BioForm
has licensed U.S. marketing rights to Aethoxysklerol(R), the
worldwide leading sclerotherapy agent, which is currently being
evaluated in a Phase III clinical trial. BioForm has also licensed
BioGlue, a new surgical adhesive product for plastic surgery
applications, which is being developed in a partnership with
CryoLife, Inc. Contact: Adam Gridley 650.286.4025 Vice President,
Corporate Development BioForm Medical, Inc. DATASOURCE: BioForm
Medical, Inc. CONTACT: Adam Gridley, Vice President, Corporate
Development, BioForm Medical, Inc., +1-650-286-4025 Web site:
http://www.bioformmedical.com/
Copyright
Bioform Medical (MM) (NASDAQ:BFRM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bioform Medical (MM) (NASDAQ:BFRM)
Historical Stock Chart
From Jul 2023 to Jul 2024